Follow
Mariam O Fofana
Title
Cited by
Cited by
Year
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
EA Kendall, MO Fofana, DW Dowdy
The Lancet Respiratory Medicine 3 (12), 963-972, 2015
2492015
When to start antiretroviral therapy in resource-limited settings
RP Walensky, LL Wolf, R Wood, MO Fofana, KA Freedberg, NA Martinson, ...
Annals of internal medicine 151 (3), 157-166, 2009
1742009
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival
RP Walensky, R Wood, MC Weinstein, NA Martinson, E Losina, ...
The Journal of infectious diseases 197 (9), 1324-1332, 2008
952008
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa
RP Walensky, R Wood, MO Fofana, NA Martinson, E Losina, MD April, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (1), 26-35, 2011
892011
The distribution of fitness costs of resistance-conferring mutations is a key determinant for the future burden of drug-resistant tuberculosis: a model-based analysis
GM Knight, C Colijn, S Shrestha, M Fofana, F Cobelens, RG White, ...
Clinical infectious diseases 61 (suppl_3), S147-S154, 2015
622015
Decolonising global health in the time of COVID-19
MO Fofana
Global Public Health 16 (8-9), 1155-1166, 2021
532021
Willingness to get the COVID-19 vaccine among residents of slum settlements
JP Aguilar Ticona, N Nery Jr, R Victoriano, MO Fofana, GS Ribeiro, ...
Vaccines 9 (9), 951, 2021
392021
Development of global health education at Johns Hopkins University School of Medicine: a student-driven initiative
D Moran, J Edwardson, CN Cuneo, S Tackett, J Aluri, A Kironji, J Cox, ...
Medical education online 20 (1), 28632, 2015
312015
Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis
MO Fofana, GM Knight, GB Gomez, RG White, DW Dowdy
PloS one 9 (5), e96389, 2014
272014
Cost-effectiveness of novel first-line treatment regimens for tuberculosis
JP Owens, MO Fofana, DW Dowdy
The International journal of tuberculosis and lung disease 17 (5), 590-596, 2013
272013
A multistrain mathematical model to investigate the role of pyrazinamide in the emergence of extensively drug-resistant tuberculosis
MO Fofana, S Shrestha, GM Knight, T Cohen, RG White, F Cobelens, ...
Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 00498-16, 2017
242017
Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis
S Shrestha, GM Knight, M Fofana, T Cohen, RG White, F Cobelens, ...
Open forum infectious diseases 1 (2), ofu073, 2014
222014
Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey
MO Fofana, N Nery Jr, JP Aguilar Ticona, EMM de Andrade Belitardo, ...
PLoS Medicine 19 (9), e1004093, 2022
162022
Effectiveness of primary and booster COVID-19 mRNA vaccination against Omicron variant SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection
ML Lind, AJ Robertson, J Silva, F Warner, AC Coppi, N Price, C Duckwall, ...
152022
The spectre of race in American medicine
MO Fofana
Medical humanities 39 (2), 137-141, 2013
132013
Time and time again: the reincarnations of coerced sterilisation
MO Fofana
Journal of Medical Ethics 48 (11), 805-809, 2022
112022
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis Lancet Respir Med, 3 (2015)
EA Kendall, MO Fofana, DW Dowdy
View PDF View article View in Scopus, 963-972, 0
9
Reply to Anthony et al.,“Protecting pyrazinamide, a priority for improving outcomes in multidrug-resistant tuberculosis treatment”
MO Fofana, DW Dowdy
Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00427-17, 2017
72017
Racial discrimination from patients: institutional strategies to establish respectful emergency department environments
AN Chary, MO Fofana, HS Kohli
Western Journal of Emergency Medicine 22 (4), 898, 2021
62021
Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA. 1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative …
ML Lind, AJ Robertson, J Silva, F Warner, AC Coppi, N Price, C Duckwall, ...
PLoS medicine 19 (12), e1004136, 2022
52022
The system can't perform the operation now. Try again later.
Articles 1–20